IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지
DOI QR코드

DOI QR Code

Regulation of Immune Responses by the Activating and Inhibitory Myeloid-Associate Immunoglobuline-Like Receptors (MAIR) (CD300)

  • Shibuya, Akira (Department of Immunology, Institute of Basic Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba) ;
  • Nakahashi-Oda, Chigusa (Department of Immunology, Institute of Basic Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba) ;
  • Tahara-Hanaoka, Satoko (Department of Immunology, Institute of Basic Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba)
  • Received : 2009.03.23
  • Accepted : 2009.03.31
  • Published : 2009.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Activating and inhibitory cell surface receptors play important roles in regulation of immune responses. Recent progress has demonstrated that many inhibitory receptors pair with activating, as well as inhibitory, isoforms, both of whose genes are located in small clusters on a chromosome. We and others identified paired activating and inhibitory immunoglobulin-like receptors, designated myeloid-associated immunoglobulin-like receptors (MAIR) (CD300). MAIR is a multigene family consisting of nine genes on a small segment of mouse chromosome 11. MAIR family receptors are preferentially expressed on myeloid cells, including macrophages, dendritic cells, granulocytes, and bone-marrow-derived cultured mast cells, and a subset of B cells and regulate activation of these cells. Thus, MAIR plays an important role in innate immunity mediated by myeloid cells.

Keywords

References

  1. Ravetch JV, Lanier LL: Immune inhibitory receptors. Science 290;84-89, 2000 https://doi.org/10.1126/science.290.5489.84
  2. Lanier LL: Face off--the interplay between activating and inhibitory immune receptors. Curr Opin Immunol 13;326-331, 2001 https://doi.org/10.1016/S0952-7915(00)00222-3
  3. Malbec O, Fong DC, Turner M, Tybulewicz VL, Cambier JC, Fridman WH, Da$\ddot{e}$ron M: Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation. J Immunol 160;1647-1658, 1998
  4. Smith KM, Wu J, Bakker AB, Phillips JH, Lanier LL: Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol 161;7-10, 1998
  5. Lanier LL, Bakker AB: The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol Today 21;611-614, 2000 https://doi.org/10.1016/S0167-5699(00)01745-X
  6. Love PE, Shores EW: ITAM multiplicity and thymocyte selection:how low can you go? Immunity 12;591-597, 2000 https://doi.org/10.1016/S1074-7613(00)80210-1
  7. Takai T, Ono M: Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family. Immunol Rev 181;215-222, 2001 https://doi.org/10.1034/j.1600-065X.2001.1810118.x
  8. Martin AM, Kulski JK, Witt C, Pontarotti P, Christiansen FT:Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol 23;81-88, 2002 https://doi.org/10.1016/S1471-4906(01)02155-X
  9. Nathan C: Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6;173-182, 2006 https://doi.org/10.1038/nri1785
  10. Kumagai H, Oki T, Tamitsu K, Feng SZ, Ono M, Nakajima H, Bao YC, Kawakami Y, Nagayoshi K, Copeland NG, Gilbert DJ, Jenkins NA, Kawakami T, Kitamura T: Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells. Biochem Biophys Res Commun 307;719-729, 2003 https://doi.org/10.1016/S0006-291X(03)01245-2
  11. Chung DH, Humphrey MB, Nakamura MC, Ginzinger DG, Seaman WE, Daws MR: CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J Immunol 171;6541-6548, 2003 https://doi.org/10.4049/jimmunol.171.12.6541
  12. Luo K, Zhang W, Sui L, Li N, Zhang M, Ma X, Zhang L, Cao X: DIgR1, a novel membrane receptor of the immunoglobulin gene superfamily, is preferentially expressed by antigen-presenting cells. Biochem Biophys Res Commun 287;35-41, 2001 https://doi.org/10.1006/bbrc.2001.5539
  13. Nakano T, Tahara-Hanaoka S, Nakahashi C, Can I, Totsuka N, Honda S, Shibuya K, Shibuya A: Activation of neutrophils by a novel triggering immunoglobulin-like receptor MAIR-IV. Mol Immunol 45;289-294, 2008 https://doi.org/10.1016/j.molimm.2007.04.011
  14. Fujimoto M, Takatsu H, Ohno H: CMRF-35-like molecule-5 constitutes novel paired receptors, with CMRF-35-like molecule-1, to transduce activation signal upon association with FcRgamma. Int Immunol 18;1499-1508, 2006 https://doi.org/10.1093/intimm/dxl083
  15. Shi L, Luo K, Xia D, Chen T, Chen G, Jiang Y, Li N, Cao X: DIgR2, dendritic cell-derived immunoglobulin receptor 2, is one representative of a family of IgSF inhibitory receptors and mediates negative regulation of dendritic cellnitiated antigen-specific T-cell responses. Blood 108;2678-2686, 2006 https://doi.org/10.1182/blood-2006-04-015404
  16. Cantoni C, Bottino C, Augugliaro R, Morelli L, Marcenaro E, Castriconi R, Vitale M, Pende D, Sivori S, Millo R, Biassoni R, Moretta L, Moretta A: Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol 29;3148-3159, 1999 https://doi.org/10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L
  17. Clark GJ, Green BJ, Hart DN: The CMRF-35H gene structure predicts for an independently expressed member of an ITIM/ITAM pair of molecules localized to human chromosome 17. Tissue Antigens 55;101-109, 2000 https://doi.org/10.1034/j.1399-0039.2000.550201.x
  18. Clark GJ, Cooper B, Fitzpatrick S, Green BJ, Hart DN: The gene encoding the immunoregulatory signaling molecule CMRF-35A localized to human chromosome 17 in close proximity to other members of the CMRF-35 family. Tissue Antigens 57;415-423, 2001 https://doi.org/10.1034/j.1399-0039.2001.057005415.x
  19. Yotsumoto K, Okoshi Y, Shibuya K, Yamazaki S, Taharaanaoka S, Honda S, Osawa M, Kuroiwa A, Matsuda Y, Tenen DG, Iwama A, Nakauchi H, Shibuya A: Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation. J Exp Med 198;223-233, 2003 https://doi.org/10.1084/jem.20021825
  20. Nakahashi C, Tahara-Hanaoka S, Totsuka N, Okoshi Y, Takai T, Ohkohchi N, Honda S, Shibuya K, Shibuya A: Dual assemblies of an activating immune receptor, MAIR-II, with ITAM-bearing adapters DAP12 and FcRgamma chain on peritoneal macrophages. J Immunol 178;765-770, 2007 https://doi.org/10.4049/jimmunol.178.2.765
  21. Okoshi Y, Tahara-Hanaoka S, Nakahashi C, Honda S, Miyamoto A, Kojima H, Nagasawa T, Shibuya K, Shibuya A: Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophilic leukemia RBL-2H3. Int Immunol 17;65-72, 2005 https://doi.org/10.1093/intimm/dxh187
  22. Takaki R, Watson SR, Lanier LL: DAP12: an adapter protein with dual functionality. Immunol Rev 214;118-129, 2006 https://doi.org/10.1111/j.1600-065X.2006.00466.x
  23. Kim MK, Huang ZY, Hwang PH, Jones BA, Sato N, Hunter S, Kim-Han TH, Worth RG, Indik ZK, Schreiber AD:Fcgamma receptor transmembrane domains: role in cell surface expression, gamma chain interaction, and phagocytosis. Blood 101;4479-4484, 2003 https://doi.org/10.1182/blood.V101.11.4479
  24. Can I, Tahara-Hanaoka S, Hitomi K, Nakano T, Nakahashida C, Kurita N, Honda S, Shibuya K, Shibuya A: Caspase-independent cell death by CD300LF (MAIR-V), an inhibitory immunoglobulin-like receptor on myeloid cells. J Immunol 180;207-213, 2008 https://doi.org/10.4049/jimmunol.180.1.207

Cited by

  1. An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E–mediated immediate hypersensitivity reactions vol.11, pp.7, 2009, https://doi.org/10.1038/ni.1886
  2. CD300F Blocks Both MyD88 and TRIF-Mediated TLR Signaling through Activation of Src Homology Region 2 Domain-Containing Phosphatase 1 vol.186, pp.11, 2009, https://doi.org/10.4049/jimmunol.1002184
  3. Synthetic Peptides Containing ITIM-Like Domains Block Expression of Inflammatory Mediators and Migration/Invasion of Cancer Cells Through Activation of SHP-1 and PI3K vol.30, pp.5, 2009, https://doi.org/10.3109/07357907.2012.664671
  4. SHPS-1 and a synthetic peptide representing its ITIM inhibit the MyD88, but not TRIF, pathway of TLR signaling through activation of SHP and PI3K in THP-1 cells vol.62, pp.4, 2009, https://doi.org/10.1007/s00011-013-0589-0
  5. The Role of Natural Cytotoxicity Receptors in Various Pathologies: Emphasis on Type I Diabetes vol.5, pp.None, 2009, https://doi.org/10.3389/fimmu.2014.00004
  6. Involvement of CD300a Phosphatidylserine Immunoreceptor in Aluminum Salt Adjuvant–Induced Th2 Responses vol.194, pp.11, 2009, https://doi.org/10.4049/jimmunol.1402915
  7. The Biology and Disease Relevance of CD300a, an Inhibitory Receptor for Phosphatidylserine and Phosphatidylethanolamine vol.194, pp.11, 2009, https://doi.org/10.4049/jimmunol.1500304
  8. Identification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor Family vol.290, pp.36, 2015, https://doi.org/10.1074/jbc.m115.643361
  9. Nrf2 activation mediates tumor-specific hepatic stellate cells-induced DIgR2 expression in dendritic cells vol.11, pp.23, 2009, https://doi.org/10.18632/aging.102554
  10. CD300a blockade enhances efferocytosis by infiltrating myeloid cells and ameliorates neuronal deficit after ischemic stroke vol.6, pp.64, 2009, https://doi.org/10.1126/sciimmunol.abe7915